STEMLINE THERAPEUTICS INC 3 SEC Filings

Filed On	Filing
23 Dec 2019	Form 3: Francomano Robert, Chief Commercial Officer Holds 100,991 shares of Common Stock
26 Apr 2018	Form 3: Hume Daniel, Director No securities owned
26 Apr 2018	Form 3: Cline Darren S, Director No securities owned
26 Apr 2018	Form 3: Sard Mark, Director Holds 16,000 shares of Common Stock
07 May 2015	Form 3: Forman Alan S, Director Holds 43,140 shares of Common Stock
23 Jan 2014	Form 3: Gionco David, Chief Accounting Officer Holds 30,000 shares of Common Stock
04 Apr 2013	Form 3: Hoberman Kenneth, Chief Operating Officer Holds 19,288 shares of Common Stock
28 Jan 2013	Form 3: Zuerblis Kenneth J, Director Holds 7,963 shares of Common Stock
28 Jan 2013	Form 3: Rowinsky Eric K, EVP, Chief Med. Off., Head R&D
28 Jan 2013	Form 3: Bergstein Ivan, Director Holds 1,815,183 shares of Common Stock
28 Jan 2013	Form 3: Hall Stephen P, VP Finance; CAO; PFO No securities owned
28 Jan 2013	Form 3: Dobmeier Eric, Director Holds 7,963 shares of Common Stock
28 Jan 2013	Form 3: Buchi J Kevin, Director Holds 13,272 shares of Common Stock
28 Jan 2013	Form 3: Bentsur Ron, Director Holds 3,252 shares of Common Stock

Comments